학술논문
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)
Document Type
Short Communication
Author
Source
In Clinical Lung Cancer September 2023 24(6):568-572
Subject
Language
ISSN
1525-7304